Baudax Bio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BXRX research report →
Companywww.baudaxbio.com
Baudax Bio, Inc. , a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics.
- CEO
- Geraldine A. Henwood
- IPO
- 2019
- Employees
- 9
- HQ
- Malvern, PA, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -452.32%
- Op Margin
- -4476.99%
- Net Margin
- -4633.18%
- ROE
- 1067.45%
- ROIC
- 974.83%
Growth & Income
- Revenue
- $1.27M · 17.50%
- Net Income
- $-58,795,000 · -197.41%
- EPS
- $-177.30 · 50.91%
- Op Income
- $-35,743,000
- FCF YoY
- 43.78%
Performance & Tape
- 52W High
- $3.47
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.29
- Beta
- 1.58
- Avg Volume
- 424.85K
Get TickerSpark's AI analysis on BXRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 9, 23 | McAndrew Natalie | other | 0 |
| Jul 3, 23 | Kim Yong Chan | other | 0 |
| Jul 3, 23 | Kim Yong Chan | other | 4,520,066 |
| Dec 15, 22 | HENWOOD GERALDINE | buy | 1,200 |
| Jun 15, 22 | Ashton William | other | 39,473 |
| Jun 15, 22 | Baskies Arnold M | other | 39,473 |
| Jun 15, 22 | CHURCHILL WINSTON J | other | 39,473 |
| Jun 15, 22 | Drechsler Andrew T | other | 39,473 |
| Jun 15, 22 | Dilmore Jillian | other | 15,467 |
| Jun 15, 22 | HENWOOD GERALDINE | other | 39,473 |
Our BXRX Coverage
We haven't published any research on BXRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BXRX Report →